Smart Insulin Or Glucose Responsive Insulin Market By Type (rapid Acting, Intermediate Acting, Long Acting, Short Acting, Premixed Type), Diseases (type 1 And Type 2 Diabetes) And Delivery Devices (smart Insulin Pen, Smart Insulin Patch Or Microneedle Array Patch, Smart Insulin Pump) - Global Industry Analysis And Forecast To 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Smart Insulin or Glucose Responsive Insulin Market, By Types

5.1.       Introduction

5.2.       Global Smart Insulin or Glucose Responsive Insulin Revenue and Market Share by Types (2017-2027)

5.2.1.  Global Smart Insulin or Glucose Responsive Insulin Revenue and Revenue Share by Types (2017-2027)

5.3.       Rapid Acting

5.3.1.  Global Rapid Acting Revenue and Growth Rate (2017-2027)

5.4.       Intermediate Acting

5.4.1.  Global Intermediate Acting Revenue and Growth Rate (2017-2027)

5.5.       Long Acting

5.5.1.  Global Long Acting Revenue and Growth Rate (2017-2027)

5.6.       Short Acting

5.6.1.  Global Short Acting Revenue and Growth Rate (2017-2027)

5.7.       Premixed Type

5.7.1.  Global Premixed Type Revenue and Growth Rate (2017-2027)

6.       Smart Insulin or Glucose Responsive Insulin Market, By Diseases

6.1.       Introduction

6.2.       Global Smart Insulin or Glucose Responsive Insulin Revenue and Market Share by Diseases (2017-2027)

6.2.1.  Global Smart Insulin or Glucose Responsive Insulin Revenue and Revenue Share by Diseases (2017-2027)

6.3.       Type 1 Diabetes

6.3.1.  Global Type 1 Diabetes Revenue and Growth Rate (2017-2027)

6.4.       Type 2 Diabetes

6.4.1.  Global Type 2 Diabetes Revenue and Growth Rate (2017-2027)

7.       Smart Insulin or Glucose Responsive Insulin Market, By Delivery Devices

7.1.       Introduction

7.2.       Global Smart Insulin or Glucose Responsive Insulin Revenue and Market Share by Delivery Devices (2017-2027)

7.2.1.  Global Smart Insulin or Glucose Responsive Insulin Revenue and Revenue Share by Delivery Devices (2017-2027)

7.3.       Smart Insulin Pen

7.3.1.  Global Smart Insulin Pen Revenue and Growth Rate (2017-2027)

7.4.       Smart Insulin Patch or Microneedle Array Patch

7.4.1.  Global Smart Insulin Patch or Microneedle Array Patch Revenue and Growth Rate (2017-2027)

7.5.       Smart Insulin Pump

7.5.1.  Global Smart Insulin Pump Revenue and Growth Rate (2017-2027)

8.       Smart Insulin or Glucose Responsive Insulin Market, By Region

8.1.       Introduction

8.2.       Global Smart Insulin or Glucose Responsive Insulin Revenue and Market Share by Regions

8.2.1.  Global Smart Insulin or Glucose Responsive Insulin Revenue by Regions (2017-2027)

8.3.       North America Smart Insulin or Glucose Responsive Insulin by Countries

8.3.1.  North America Smart Insulin or Glucose Responsive Insulin Revenue and Growth Rate (2017-2027)

8.3.2.  North America Smart Insulin or Glucose Responsive Insulin Revenue by Countries (2017-2027)

8.3.3.  North America Smart Insulin or Glucose Responsive Insulin Revenue (Million USD) by Countries (2017-2027)

8.3.4.  U.S.

8.3.4.1.    United States Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5.  Canada

8.3.5.1.    Canada Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.6.  Mexico

8.3.6.1.    Mexico Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.       Europe Smart Insulin or Glucose Responsive Insulin by Countries

8.4.1.  Europe Smart Insulin or Glucose Responsive Insulin Revenue and Growth Rate (2017-2027)

8.4.2.  Europe Smart Insulin or Glucose Responsive Insulin Revenue by Countries (2017-2027)

8.4.3.  Europe Smart Insulin or Glucose Responsive Insulin Revenue (Million USD) by Countries (2017-2027)

8.4.4.  Germany

8.4.4.1.    Germany Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5.  UK

8.4.5.1.    UK Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  France

8.4.6.1.    France Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  Russia

8.4.7.1.    Russia Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Italy

8.4.8.1.    Italy Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.9.  Rest of Europe

8.4.9.1.    Rest of Europe Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.       Asia-Pacific

8.5.1.  Asia-Pacific Smart Insulin or Glucose Responsive Insulin Revenue and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Smart Insulin or Glucose Responsive Insulin Revenue by Countries (2017-2027)

8.5.3.  Asia-Pacific Smart Insulin or Glucose Responsive Insulin Revenue (Million USD) by Countries (2017-2027)

8.5.4.  China

8.5.4.1.    China Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.  Japan

8.5.5.1.    Japan Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.2.     

8.5.6.  Korea

8.5.6.1.    Korea Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7.  India

8.5.7.1.    India Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  Southeast Asia

8.5.8.1.    Southeast Asia Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.9.  Rest of Asia-Pacific

8.5.9.1.    Rest of Asia-Pacific Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.       South America

8.6.1.  South America Smart Insulin or Glucose Responsive Insulin Revenue and Growth Rate (2017-2027)

8.6.2.  South America Smart Insulin or Glucose Responsive Insulin Revenue by Countries (2017-2027)

8.6.3.  South America Smart Insulin or Glucose Responsive Insulin Revenue (Million USD) by Countries (2017-2027)

8.6.4.  Brazil

8.6.4.1.    Brazil Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5.  Argentina

8.6.5.1.    Argentina Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Columbia

8.6.6.1.    Columbia Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.7.  Rest of South America

8.6.7.1.    Rest of South America Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.       Middle East and Africa

8.7.1.  Middle East and Africa Smart Insulin or Glucose Responsive Insulin Revenue and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Smart Insulin or Glucose Responsive Insulin Revenue by Countries (2017-2027)

8.7.3.  Middle East and Africa Smart Insulin or Glucose Responsive Insulin Revenue (Million USD) by Countries (2017-2027)

8.7.4.  Saudi Arabia

8.7.4.1.    Saudi Arabia Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5.  United Arab Emirates

8.7.5.1.    United Arab Emirates Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  Egypt

8.7.6.1.    Egypt Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  Nigeria

8.7.7.1.    Nigeria Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  South Africa

8.7.8.1.    South Africa Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.    Rest of Middle East and Africa Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.       Juvenile Diabetes Research Foundation Ltd

9.1.1.  Business Overview

9.1.2.  Types Portfolio

9.1.3.  Strategic Developments

9.1.4.  Revenue and Market Share

9.2.       Novo Nordisk A/S

9.2.1.  Business Overview

9.2.2.  Types Portfolio

9.2.3.  Strategic Developments

9.2.4.  Revenue and Market Share

9.3.       Sanofi

9.3.1.  Business Overview

9.3.2.  Types Portfolio

9.3.3.  Strategic Developments

9.3.4.  Revenue and Market Share

9.4.       Eli Lilly and Company

9.4.1.  Business Overview

9.4.2.  Types Portfolio

9.4.3.  Strategic Developments

9.4.4.  Revenue and Market Share

9.5.       Merck & Co., Inc.

9.5.1.  Business Overview

9.5.2.  Types Portfolio

9.5.3.  Strategic Developments

9.5.4.  Revenue and Market Share

9.6.       MannKind Corporation

9.6.1.  Business Overview

9.6.2.  Types Portfolio

9.6.3.  Strategic Developments

9.6.4.  Revenue and Market Share

9.7.       ADOCIA

9.7.1.  Business Overview

9.7.2.  Types Portfolio

9.7.3.  Strategic Developments

9.7.4.  Revenue and Market Share

9.8.       Biodel Inc.

9.8.1.  Business Overview

9.8.2.  Types Portfolio

9.8.3.  Strategic Developments

9.8.4.  Revenue and Market Share

9.9.       Biocon and Halozyme, Inc.

9.9.1.  Business Overview

9.9.2.  Types Portfolio

9.9.3.  Strategic Developments

9.9.4.  Revenue and Market Share

10.   Global Smart Insulin or Glucose Responsive Insulin Market Competition, by Manufacturer

10.1.    Global Smart Insulin or Glucose Responsive Insulin Revenue and Market Share by Manufacturer (2017-2017)

10.2.    Global Smart Insulin or Glucose Responsive Insulin Price by Region (2017-2017)

10.3.    Top 5 Smart Insulin or Glucose Responsive Insulin Manufacturer Market Share

10.4.    Market Competition Trend

11.   Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.1.    Global Smart Insulin or Glucose Responsive Insulin Revenue (Millions USD) and Growth Rate (2027-2023)

11.2.    Smart Insulin or Glucose Responsive Insulin Market Forecast by Regions (2027-2023)

11.2.1.      North America Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.1.1. United States Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.1.2. Canada Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.1.3. Mexico Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.2.      Europe Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.2.1. Germany Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.2.2. United Kingdom Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.2.3. France Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.2.4. Russia Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.2.5. Italy Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.2.6. Rest of the Europe Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.3.      Asia-Pacific Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.3.1. China Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.3.2. Japan Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.3.3. Korea Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.3.4. India Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.3.5. Southeast Asia Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.3.6. Rest of Asia-Pacific Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.4.      South America Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.4.1. Brazil Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.4.2. Argentina Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.4.3. Columbia Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.4.4. Rest of South America Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.5.      Middle East and Africa Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.5.1. Saudi Arabia Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.5.2. UAE Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.5.3. Egypt Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.5.4. Nigeria Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.5.5. South Africa Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.2.5.6. Rest of MEA Smart Insulin or Glucose Responsive Insulin Market Forecast (2027-2023)

11.3.    Smart Insulin or Glucose Responsive Insulin Market Forecast by Types (2027-2023)

11.3.1.      Global Smart Insulin or Glucose Responsive Insulin Revenue Forecast by Types (2027-2023)

11.3.2.      Global Smart Insulin or Glucose Responsive Insulin Revenue Market Share Forecast by Types (2027-2023)

11.4.    Smart Insulin or Glucose Responsive Insulin Market Forecast by Diseases (2027-2023)

11.4.1.      Global Smart Insulin or Glucose Responsive Insulin Revenue Forecast by Diseases (2027-2023)

11.4.2.      Global Smart Insulin or Glucose Responsive Insulin Revenue Market Share Forecast by Diseases (2027-2023)

11.5.    Smart Insulin or Glucose Responsive Insulin Market Forecast by Delivery Devices (2027-2023)

11.5.1.      Global Smart Insulin or Glucose Responsive Insulin Revenue Forecast by Delivery Devices (2027-2023)

11.5.2.      Global Smart Insulin or Glucose Responsive Insulin Revenue Market Share Forecast by Delivery Devices (2027-2023)

---

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Smart Insulin or Glucose Responsive Insulin Market.

---

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country